Azim, H. A., S. Dawood, N. El‐Saghir, L. Kassem, and H. A. Azim, Understanding the benefits and challenges of first‐line cyclin‐dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal women, : John Wiley & Sons, Ltd (10.1111), Submitted. Abstract
n/a
Kassem, L., K. S. Shohdy, N. F. Makady, D. S. Salem, N. Ebrahim, and mostafa eldaly, Efficacy and Safety of Targeting Androgen Receptor in Advanced Breast Cancer: A Systematic Review, , vol. 14, pp. 1 - 11, 2018. Abstract
n/a
Azim, H. A., L. Kassem, K. S. Shohdy, B. Eshaak, shady elia anis, and N. S. Kamal, Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin, , vol. 22, issue 1, pp. 141 - 148, 2019. Abstract
n/a
Choucair, A., T. H. Pham, S. Omarjee, J. Jacquemetton, L. Kassem, O. Trédan, J. Rambaud, E. Marangoni, L. Corbo, and I. Treilleux, The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer, , vol. 38, issue 21: Nature Publishing Group, pp. 4015, 2019. Abstract
n/a
Kassem, L., K. S. Shohdy, A. M. Abdel-Azeez, and H. Attia, Is the Fixed-Dose Intravenous Trastuzumab Policy Warranted in Limited-Resource Settings?, , vol. 5: American Society of Clinical Oncology, 2019. Abstract
n/a
Rabea, A. M., A. Shafik, B. Refky, E. Shash, K. A. Aziz, L. Kassem, N. Rashad, and O. Abdel-Rahman, The State of Lung Cancer in Egypt: Progress Is at Hand, , Submitted. Abstract
n/a
Azim, H. A., A. Omar, H. Atef, H. Zawahry, M. K. Shaker, A. H. K. Abdelmaksoud, M. EzzElarab, O. Abdel-Rahman, M. Ismail, and L. Kassem, Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study), , vol. 5: Dove Press, pp. 109, 2018. Abstract
n/a
Kassem, L., K. S. Shohdy, S. Lasheen, O. Abdel-Rahman, A. Ali, and R. R. Abdel-Malek, Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review, : Elsevier, 2018. Abstract
n/a
Montagna, G., D. Anderson, J. Bochenek-Cibor, I. Bozovic-Spasojevic, C. Campos, S. Cavallero, I. Durutovic, M. O. G. Cuadra, T. Irfan, and L. Joly, How to become a breast cancer specialist in 2018: The point of view of the second cohort of the Certificate of Competence in Breast Cancer (CCB2), , vol. 43: Churchill Livingstone, pp. 18 - 21, 2019. Abstract
n/a
Lattouf, H., L. Kassem, J. Jacquemetton, A. Choucair, C. Poulard, O. Trédan, L. Corbo, M. Diab‐Assaf, N. Hussein, and I. Treilleux, LKB1 regulates PRMT5 activity in breast cancer, , vol. 144, issue 3: John Wiley & Sons, Inc. Hoboken, USA, pp. 595 - 606, 2019. Abstract
n/a